• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt.

作者信息

De Winter Sabrina, Verelst Sandra, Wauters Joost, Van der Linden Lorenz, Verslype Chris, Willems Ludo, Spriet Isabel

机构信息

Clinical Pharmacology and Pharmacotherapy, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium,

出版信息

Eur J Clin Pharmacol. 2014 Mar;70(3):377-8. doi: 10.1007/s00228-013-1629-y. Epub 2013 Dec 19.

DOI:10.1007/s00228-013-1629-y
PMID:24352633
Abstract
摘要

相似文献

1
Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后的药代动力学变化。
Eur J Clin Pharmacol. 2014 Mar;70(3):377-8. doi: 10.1007/s00228-013-1629-y. Epub 2013 Dec 19.
2
The 'Gerstmann's Syndrome' of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right.经颈静脉肝内门体分流术的“格斯特曼综合征”：应选择左侧还是右侧？
Liver Int. 2009 Sep;29(8):1129-31. doi: 10.1111/j.1478-3231.2009.02094.x.
3
A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.经颈静脉肝内门体分流术诱发的肝肺高血压病例报告。
Chest. 2021 Apr;159(4):e193-e196. doi: 10.1016/j.chest.2020.11.014. Epub 2021 Apr 6.
4
[Transcaval transjugular intrahepatic portosystemic shunt: preliminary clinical results].
Zhonghua Gan Zang Bing Za Zhi. 2004 Dec;12(12):761-2.
5
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.CXCL9 是接受经颈静脉肝内门体分流术治疗的肝硬化患者的预后标志物。
J Hepatol. 2015 Feb;62(2):332-9. doi: 10.1016/j.jhep.2014.09.032. Epub 2014 Oct 17.
6
[Hemolytic anemia secondary to the placement of a portosystemic stented shunt].[门静脉系统支架分流术后继发溶血性贫血]
Cir Cir. 2013 Mar-Apr;81(2):143-7.
7
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
8
[Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].经颈静脉肝内门体分流术联合Viatorr覆膜支架植入术：3例报告
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):294-6.
9
Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.经颈静脉肝内门体分流术治疗门静脉高压后延迟性肝破裂。
World J Gastroenterol. 2012 Dec 28;18(48):7405-8. doi: 10.3748/wjg.v18.i48.7405.
10
[Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].经颈静脉肝内门体分流术治疗肝硬化食管胃底静脉曲张破裂出血：目标人群及时机
Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):402-407. doi: 10.3760/cma.j.issn.1007-3418.2017.06.002.

本文引用的文献

1
The impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patient.经颈静脉肝内门体分流术对危重症患者卡泊芬净药代动力学的影响。
Pharmacology. 2012;90(5-6):247-50. doi: 10.1159/000342906. Epub 2012 Sep 20.
2
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.肝功能不全患者的药代动力学及剂量调整
Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2.
3
Dose adjustment in patients with liver disease.肝病患者的剂量调整。
Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005.
4
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.肝硬化患者肝脏和肠道细胞色素P450 3A活性：经颈静脉肝内门体分流术的影响
Hepatology. 2001 Dec;34(6):1103-8. doi: 10.1053/jhep.2001.29306.